VALERA MESSENGER VACCINES Trademark

Trademark Overview

On Friday, February 7, 2014, a trademark application was filed for VALERA MESSENGER VACCINES with the United States Patent and Trademark Office. The USPTO has given the VALERA MESSENGER VACCINES trademark a serial number of 86187862. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 21, 2018. This trademark is owned by Moderna Therapeutics, Inc.. The VALERA MESSENGER VACCINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines; pharmaceutical preparations, namely, nucleic acid preparations for the treatment and prevention of infectious diseases; medicines, namely, nucleic acid therapeutics for the treatment and prevention of infectious diseases; biological preparations, namely, nucleic acid preparations for the prevention and treatment of infectious diseases; biotherapeutics, namely, nucleic acid therapeutics for the prevention and treatment of infectious diseases; biosimilars in the nature of therapeutic agents, namely, nucleic acid therapeutics for the prevention and treatment of infectious diseases; vaccine adjuvants

Scientific research in the fields of immunopharmaceuticals and vaccines; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics for the prevention and treatment of infections or diseases
valera messenger vaccines

General Information

Serial Number86187862
Word MarkVALERA MESSENGER VACCINES
Filing DateFriday, February 7, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 21, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2015

Trademark Statements

Disclaimer with Predetermined Text"MESSENGER VACCINES"
Goods and ServicesVaccines; pharmaceutical preparations, namely, nucleic acid preparations for the treatment and prevention of infectious diseases; medicines, namely, nucleic acid therapeutics for the treatment and prevention of infectious diseases; biological preparations, namely, nucleic acid preparations for the prevention and treatment of infectious diseases; biotherapeutics, namely, nucleic acid therapeutics for the prevention and treatment of infectious diseases; biosimilars in the nature of therapeutic agents, namely, nucleic acid therapeutics for the prevention and treatment of infectious diseases; vaccine adjuvants
Goods and ServicesScientific research in the fields of immunopharmaceuticals and vaccines; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics for the prevention and treatment of infections or diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 20, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 20, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMODERNATX, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02141
Party NameModerna Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameModerna Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, May 21, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 21, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2017EXTENSION 5 GRANTED
Friday, October 13, 2017EXTENSION 5 FILED
Friday, October 13, 2017TEAS EXTENSION RECEIVED
Saturday, April 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 30, 2017EXTENSION 4 GRANTED
Thursday, March 30, 2017EXTENSION 4 FILED
Thursday, March 30, 2017TEAS EXTENSION RECEIVED
Tuesday, November 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2016EXTENSION 3 GRANTED
Thursday, October 13, 2016EXTENSION 3 FILED
Wednesday, November 2, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 13, 2016TEAS EXTENSION RECEIVED
Wednesday, June 15, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 15, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 13, 2016EXTENSION 2 GRANTED
Tuesday, April 12, 2016EXTENSION 2 FILED
Wednesday, May 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 12, 2016TEAS EXTENSION RECEIVED
Tuesday, October 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 9, 2015EXTENSION 1 GRANTED
Friday, October 9, 2015EXTENSION 1 FILED
Friday, October 9, 2015TEAS EXTENSION RECEIVED
Friday, June 5, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 5, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 14, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 14, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 14, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, January 13, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 13, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, January 13, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 13, 2015PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, January 7, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 23, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, December 9, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 8, 2014ASSIGNED TO LIE
Saturday, November 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 22, 2014EXAMINER'S AMENDMENT ENTERED
Saturday, November 22, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, November 22, 2014EXAMINERS AMENDMENT E-MAILED
Saturday, November 22, 2014EXAMINERS AMENDMENT -WRITTEN
Thursday, November 13, 2014ASSIGNED TO EXAMINER
Friday, November 7, 2014ASSIGNED TO EXAMINER
Thursday, November 6, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 6, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 6, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 8, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 8, 2014NON-FINAL ACTION E-MAILED
Thursday, May 8, 2014NON-FINAL ACTION WRITTEN
Tuesday, April 29, 2014ASSIGNED TO EXAMINER
Thursday, February 20, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 11, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

vaccines messenger valera diseases prevention treatment namely infectious acid nucleic therapeutics preparations scientific